GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Issuance of Debt

Incanthera (AQSE:INC) Issuance of Debt : £0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Issuance of Debt?

Incanthera's Issuance of Debt for the six months ended in Sep. 2023 was £0.00 Mil.

Incanthera's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00 Mil.


Incanthera Issuance of Debt Historical Data

The historical data trend for Incanthera's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Issuance of Debt Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Issuance of Debt
- - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Issuance of Debt Get a 7-Day Free Trial - - - - -

Incanthera Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Incanthera's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines